Journal of Clinical Hypertension

metrics 2024

Fostering Collaboration for Cardiovascular Excellence

Introduction

Journal of Clinical Hypertension, published by WILEY, is a leading open-access journal focused on advancing the understanding and treatment of hypertension and related cardiovascular conditions. With an ISSN of 1524-6175 and an E-ISSN of 1751-7176, the journal provides a vital platform for researchers, healthcare professionals, and students alike to disseminate high-quality, peer-reviewed research. Since transitioning to open access in 2021, it has increased its reach and accessibility, ensuring critical information is available to a broader audience. The journal holds an impressive position in the Scopus ranks, nestled within the Q2 quartile across key disciplines including Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Internal Medicine, indicating a strong impact on the scientific community. With articles converging from 2001 to 2024, it not only highlights contemporary developments but also contributes to the ongoing dialogue in the field. Researchers are encouraged to submit their findings on hypertension, treatment methodologies, and epidemiology to further enhance the collective knowledge in this crucial area of health.

Metrics 2024

SCIMAGO Journal Rank0.71
Journal Impact Factor2.70
Journal Impact Factor (5 years)3.10
H-Index81
Journal IF Without Self2.70
Eigen Factor0.01
Normal Eigen Factor1.52
Influence0.88
Immediacy Index0.50
Cited Half Life5.60
Citing Half Life6.90
JCI0.56
Total Documents4286
WOS Total Citations5569
SCIMAGO Total Citations23291
SCIMAGO SELF Citations2236
Scopus Journal Rank0.71
Cites / Document (2 Years)2.49
Cites / Document (3 Years)2.38
Cites / Document (4 Years)2.33

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #88/387
Percentile 77.26
Quartile Q1
Internal Medicine in Medicine
Rank #45/167
Percentile 73.05
Quartile Q2
Endocrinology, Diabetes and Metabolism in Medicine
Rank #93/244
Percentile 61.89
Quartile Q2

IF (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 34/96
Percentile 65.10
Quartile Q2

JCI (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 43/96
Percentile 55.21
Quartile Q2

Quartile History

Similar Journals

BLOOD PRESSURE

Empowering professionals with evidence-based cardiovascular findings.
Publisher: TAYLOR & FRANCIS LTDISSN: 0803-7051Frequency: 6 issues/year

BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.

HYPERTENSION

Connecting clinicians and researchers in hypertension.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0194-911XFrequency: 12 issues/year

HYPERTENSION, published by Lippincott Williams & Wilkins, is a preeminent journal in the field of cardiovascular medicine, focusing on the latest research, therapies, and clinical practices related to hypertension and its associated disorders. With a distinguished Q1 ranking in Internal Medicine and a commendable Scopus rank of #12 out of 167 in its category, it occupies a vital position within the academic community, appealing to researchers, clinicians, and educators alike. The journal has been disseminating impactful findings since 1979 and continues to influence the discourse on hypertension through rigorous peer-reviewed articles, reviews, and studies designed to elevate understanding and treatment of this prevalent condition. HYPERTENSION remains an essential resource for professionals keen on advancing their knowledge in this critical area of medicine, fostering innovations that ultimately improve patient care.

HYPERTENSION IN PREGNANCY

Empowering Global Dialogue on Pregnancy Hypertension
Publisher: TAYLOR & FRANCIS INCISSN: 1064-1955Frequency: 3 issues/year

HYPERTENSION IN PREGNANCY is a leading academic journal dedicated to the critical study of hypertensive disorders during pregnancy, a crucial area of maternal and fetal health. Published by Taylor & Francis Inc, this journal boasts an Open Access policy since 2023, ensuring that research findings are freely accessible to a global audience. With an ISSN of 1064-1955 and E-ISSN of 1525-6065, it offers a platform for high-quality research and review articles since its inception in 1982. The journal holds a Q3 category ranking in both Internal Medicine and Obstetrics and Gynecology, reflecting its reputable standing within the scientific community. As of 2023, it ranks among the top quartile publications in its field, with Scopus ranking it 86/209 in Obstetrics and Gynecology and 83/167 in Internal Medicine. This journal aims to foster dialogue among researchers, clinicians, and policymakers regarding the management and implications of hypertension in pregnancy, promoting advancements in care and research methodologies. Located in Philadelphia, PA, it continues to be an invaluable resource for those invested in improving maternal health outcomes and advancing the field.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Elevating knowledge in nephrology and hypertension.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1062-4821Frequency: 6 issues/year

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and research in the fields of nephrology and hypertension. Since its inception in 1992, this journal has been an essential resource for professionals seeking to stay at the forefront of kidney health and blood pressure management. With a distinguished ranking in the top quartile (Q1) for both Internal Medicine and Nephrology as of 2023, the journal is recognized for its high impact, currently holding a Scopus rank of #16 out of 81 in Nephrology, positioning it in the 80th percentile. Although not an open access journal, it provides crucial insights and expert opinions that cater to researchers, clinicians, and students committed to improving patient outcomes through evidence-based practice. The journal continues to emphasize its objectives of disseminating pivotal findings and fostering discussions that bridge the gap between clinical practice and research, making it an invaluable asset in the evolving landscape of nephrology and hypertension.

Saudi Journal of Kidney Diseases and Transplantation

Driving progress in nephrology and organ transplantation.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-2442Frequency: 6 issues/year

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

CLINICAL AND EXPERIMENTAL HYPERTENSION

Bridging clinical practice and experimental research.
Publisher: TAYLOR & FRANCIS INCISSN: 1064-1963Frequency: 8 issues/year

Clinical and Experimental Hypertension, published by Taylor & Francis Inc, is a crucial resource in the fields of internal medicine and physiology. With its inaugural publication dating back to 1978, this esteemed journal has successfully merged decades of research, providing a platform for the latest advancements in hypertension studies. Operating without an open access model, it is configured to serve a specialized audience of researchers, clinicians, and students who are dedicated to exploring innovative treatment modalities and understanding the complexities of hypertensive diseases. Ranked in the Q3 category in both Internal Medicine and Physiology, this journal accomplishes a commendable standing in the academic community, exemplified by its Scopus rankings which position it within the median percentile range in its field. By disseminating high-quality research and fostering scientific dialogue, Clinical and Experimental Hypertension plays a pivotal role in shaping contemporary understanding and clinical practices concerning hypertension management.

Current Hypertension Reviews

Advancing Insights in Hypertension Management
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4021Frequency:

Current Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.

Hypertension Research in Pregnancy

Navigating the complexities of hypertension in pregnancy for better outcomes.
Publisher: JAPAN SOC STUDY HYPERTENSION PREGNANCYISSN: 2187-5987Frequency: 2 issues/year

Hypertension Research in Pregnancy is a specialized journal dedicated to advancing the understanding of hypertension during pregnancy, an area critical for both maternal and fetal health. Published by the Japan Society for the Study of Hypertension in Pregnancy, this journal serves as a platform for researchers, clinicians, and healthcare professionals who are committed to improving outcomes in this vital field. Although currently not an open-access publication, Hypertension Research in Pregnancy disseminates rigorous scientific research and reviews that forge a path for innovative therapeutic strategies and clinical practices. With an emphasis on the latest findings and methodological advancements, the journal aims to address key challenges and promote best practices in care for hypertensive disorders in pregnancy. As a repository of knowledge and a catalyst for collaboration, it plays a crucial role in shaping future research directions and clinical interventions, making it an essential resource for anyone involved in obstetric care and maternal-fetal medicine.

BLOOD PRESSURE MONITORING

Empowering healthcare through rigorous scholarship.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1359-5237Frequency: 6 issues/year

BLOOD PRESSURE MONITORING is a distinguished academic journal published by Lippincott Williams & Wilkins, dedicated to advancing the study of blood pressure measurement and management across various medical disciplines. With an ISSN of 1359-5237 and an E-ISSN of 1473-5725, this journal has consistently contributed to the field since its inception in 1996, continuing to provide invaluable insights through 2024. Notably, the journal ranks in the Q2 quartile for Advanced and Specialized Nursing and Assessment and Diagnosis, illustrating its influence in these areas, while also making significant contributions to Cardiology, Internal Medicine, and broader Medical research. Although it does not currently offer open access, BLOOD PRESSURE MONITORING remains essential reading for researchers, healthcare professionals, and students, eager to stay at the forefront of blood pressure research and its critical implications in clinical practice. The journal's commitment to quality and rigor makes it a vital resource for anyone involved in the continuously evolving fields of cardiovascular health and patient monitoring.

KARDIOLOGIYA

Advancing Cardiovascular Knowledge Since 1961
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.